The prognostic influence of the proliferative discordance in metastatic pancreatic neuroendocrine carcinoma revealed by peptide receptor radionuclide therapy: Case report and review of literature

RATIONALE: Pancreatic neuroendocrine tumors (pNET) are rare slowly growing tumors with a high metastatic potential. Peptide receptor radionuclide therapy (PRRT) with radiolabeled analogues has been developed as a new tool for the management of metastatic well-differentiated (grade 1 and 2) neuroendo...

Descripción completa

Detalles Bibliográficos
Autores principales: Montanier, Nathanaëlle, Joubert-Zakeyh, Juliette, Pétorin, Caroline, Montoriol, Pierre François, Maqdasy, Salwan, Kelly, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313014/
https://www.ncbi.nlm.nih.gov/pubmed/28178157
http://dx.doi.org/10.1097/MD.0000000000006062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313014/
https://www.ncbi.nlm.nih.gov/pubmed/28178157
http://dx.doi.org/10.1097/MD.0000000000006062

Ejemplares similares